[{"from": "human", "value": "Could you give me a brief overview of this molecule? [C][C][N][Branch1][Ring2][C][Ring1][Ring2][C][C@H1][Branch2][Ring1][=Branch1][C][=C][C][=Branch1][=Branch2][=C][Branch1][Branch1][C][=C][Ring1][=Branch1][Cl][C][Branch1][C][F][Branch1][C][F][F][N][C][=N][C][=N][C][=C][Ring1][=Branch1][C][=C][C][=C][Ring1][=Branch1][C][=Branch1][C][=O][N]"}, {"from": "gpt", "value": "The molecule is an orally available inhibitor of the serine/threonine protein kinases ribosomal protein S6 Kinase (p70S6K) and Akt (protein kinase B), with potential antineoplastic activity. Upon administration, p70S6K/Akt inhibitor M-2698 binds to and inhibits the activity of p70S6K and Akt. This prevents the activation of the PI3K/Akt/p70S6K signaling pathway and inhibits tumor cell proliferation in cancer cells that have an overactivated PI3K/Akt/p70S6K signaling pathway. Constitutive activation and dysregulated signaling of the PI3K/Akt/p70S6K pathway are frequently associated with tumorigenesis of many tumor types; targeting multiple kinases in this pathway is more efficacious than targeting a single kinase."}]